nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—alcohol dependence—pancreatitis	0.899	1	CtDrD
Naltrexone—Heat stroke—Propantheline—pancreatitis	0.0115	0.172	CcSEcCtD
Naltrexone—Rash papular—Hyoscyamine—pancreatitis	0.00289	0.0431	CcSEcCtD
Naltrexone—Ileus paralytic—Hyoscyamine—pancreatitis	0.00249	0.0371	CcSEcCtD
Naltrexone—Thirst—Propantheline—pancreatitis	0.00161	0.0239	CcSEcCtD
Naltrexone—Paranoia—Hyoscyamine—pancreatitis	0.00158	0.0236	CcSEcCtD
Naltrexone—Naloxone—TLR4—pancreatitis	0.00157	0.889	CrCbGaD
Naltrexone—Laryngitis—Hyoscyamine—pancreatitis	0.0015	0.0223	CcSEcCtD
Naltrexone—Delirium—Hyoscyamine—pancreatitis	0.00125	0.0187	CcSEcCtD
Naltrexone—Gastrooesophageal reflux disease—Hyoscyamine—pancreatitis	0.00119	0.0178	CcSEcCtD
Naltrexone—Muscle twitching—Hyoscyamine—pancreatitis	0.0011	0.0164	CcSEcCtD
Naltrexone—Blood pressure increased—Hyoscyamine—pancreatitis	0.00108	0.0161	CcSEcCtD
Naltrexone—Injection site reaction—Hyoscyamine—pancreatitis	0.00107	0.016	CcSEcCtD
Naltrexone—Hyperkinesia—Hyoscyamine—pancreatitis	0.00094	0.014	CcSEcCtD
Naltrexone—Tension—Propantheline—pancreatitis	0.000904	0.0135	CcSEcCtD
Naltrexone—Nervousness—Propantheline—pancreatitis	0.000894	0.0133	CcSEcCtD
Naltrexone—Swelling—Hyoscyamine—pancreatitis	0.000887	0.0132	CcSEcCtD
Naltrexone—Disorientation—Hyoscyamine—pancreatitis	0.000875	0.013	CcSEcCtD
Naltrexone—Vision blurred—Propantheline—pancreatitis	0.000868	0.0129	CcSEcCtD
Naltrexone—Nasal congestion—Hyoscyamine—pancreatitis	0.000859	0.0128	CcSEcCtD
Naltrexone—Atrial fibrillation—Hyoscyamine—pancreatitis	0.000826	0.0123	CcSEcCtD
Naltrexone—Thirst—Hyoscyamine—pancreatitis	0.000822	0.0122	CcSEcCtD
Naltrexone—Palpitations—Propantheline—pancreatitis	0.000814	0.0121	CcSEcCtD
Naltrexone—Lethargy—Hyoscyamine—pancreatitis	0.000799	0.0119	CcSEcCtD
Naltrexone—Dry mouth—Propantheline—pancreatitis	0.000767	0.0114	CcSEcCtD
Naltrexone—Psychotic disorder—Hyoscyamine—pancreatitis	0.000764	0.0114	CcSEcCtD
Naltrexone—Confusional state—Propantheline—pancreatitis	0.000758	0.0113	CcSEcCtD
Naltrexone—Anaphylactic shock—Propantheline—pancreatitis	0.000752	0.0112	CcSEcCtD
Naltrexone—Irritability—Hyoscyamine—pancreatitis	0.000747	0.0111	CcSEcCtD
Naltrexone—Tachycardia—Propantheline—pancreatitis	0.000733	0.0109	CcSEcCtD
Naltrexone—Dehydration—Hyoscyamine—pancreatitis	0.000728	0.0108	CcSEcCtD
Naltrexone—Insomnia—Propantheline—pancreatitis	0.00068	0.0101	CcSEcCtD
Naltrexone—Somnolence—Propantheline—pancreatitis	0.000668	0.00995	CcSEcCtD
Naltrexone—Angina pectoris—Hyoscyamine—pancreatitis	0.000659	0.00981	CcSEcCtD
Naltrexone—Constipation—Propantheline—pancreatitis	0.000643	0.00957	CcSEcCtD
Naltrexone—Feeling abnormal—Propantheline—pancreatitis	0.000619	0.00922	CcSEcCtD
Naltrexone—Depression—Hyoscyamine—pancreatitis	0.000601	0.00896	CcSEcCtD
Naltrexone—Urticaria—Propantheline—pancreatitis	0.000597	0.00889	CcSEcCtD
Naltrexone—Acute coronary syndrome—Hyoscyamine—pancreatitis	0.000595	0.00885	CcSEcCtD
Naltrexone—Myocardial infarction—Hyoscyamine—pancreatitis	0.000591	0.0088	CcSEcCtD
Naltrexone—Conjunctivitis—Hyoscyamine—pancreatitis	0.000586	0.00873	CcSEcCtD
Naltrexone—Hypersensitivity—Propantheline—pancreatitis	0.000554	0.00825	CcSEcCtD
Naltrexone—Asthenia—Propantheline—pancreatitis	0.000539	0.00803	CcSEcCtD
Naltrexone—Hallucination—Hyoscyamine—pancreatitis	0.000539	0.00802	CcSEcCtD
Naltrexone—Dizziness—Propantheline—pancreatitis	0.000497	0.0074	CcSEcCtD
Naltrexone—Vomiting—Propantheline—pancreatitis	0.000478	0.00712	CcSEcCtD
Naltrexone—Mental disorder—Hyoscyamine—pancreatitis	0.000474	0.00706	CcSEcCtD
Naltrexone—Rash—Propantheline—pancreatitis	0.000474	0.00706	CcSEcCtD
Naltrexone—Dermatitis—Propantheline—pancreatitis	0.000473	0.00705	CcSEcCtD
Naltrexone—Headache—Propantheline—pancreatitis	0.000471	0.00701	CcSEcCtD
Naltrexone—Tension—Hyoscyamine—pancreatitis	0.000463	0.00689	CcSEcCtD
Naltrexone—Dysgeusia—Hyoscyamine—pancreatitis	0.000462	0.00687	CcSEcCtD
Naltrexone—Nervousness—Hyoscyamine—pancreatitis	0.000458	0.00682	CcSEcCtD
Naltrexone—Nausea—Propantheline—pancreatitis	0.000446	0.00665	CcSEcCtD
Naltrexone—Vision blurred—Hyoscyamine—pancreatitis	0.000444	0.00662	CcSEcCtD
Naltrexone—Agitation—Hyoscyamine—pancreatitis	0.000433	0.00645	CcSEcCtD
Naltrexone—Angioedema—Hyoscyamine—pancreatitis	0.000431	0.00641	CcSEcCtD
Naltrexone—Syncope—Hyoscyamine—pancreatitis	0.000423	0.00629	CcSEcCtD
Naltrexone—Palpitations—Hyoscyamine—pancreatitis	0.000417	0.0062	CcSEcCtD
Naltrexone—Loss of consciousness—Hyoscyamine—pancreatitis	0.000414	0.00617	CcSEcCtD
Naltrexone—Convulsion—Hyoscyamine—pancreatitis	0.000408	0.00608	CcSEcCtD
Naltrexone—Chest pain—Hyoscyamine—pancreatitis	0.000401	0.00598	CcSEcCtD
Naltrexone—Anxiety—Hyoscyamine—pancreatitis	0.0004	0.00596	CcSEcCtD
Naltrexone—Dry mouth—Hyoscyamine—pancreatitis	0.000392	0.00584	CcSEcCtD
Naltrexone—Confusional state—Hyoscyamine—pancreatitis	0.000388	0.00578	CcSEcCtD
Naltrexone—Anaphylactic shock—Hyoscyamine—pancreatitis	0.000385	0.00573	CcSEcCtD
Naltrexone—Oedema—Hyoscyamine—pancreatitis	0.000385	0.00573	CcSEcCtD
Naltrexone—Shock—Hyoscyamine—pancreatitis	0.000378	0.00564	CcSEcCtD
Naltrexone—Tachycardia—Hyoscyamine—pancreatitis	0.000375	0.00559	CcSEcCtD
Naltrexone—Hyperhidrosis—Hyoscyamine—pancreatitis	0.000372	0.00554	CcSEcCtD
Naltrexone—Insomnia—Hyoscyamine—pancreatitis	0.000348	0.00518	CcSEcCtD
Naltrexone—Dyspnoea—Hyoscyamine—pancreatitis	0.000343	0.00511	CcSEcCtD
Naltrexone—Somnolence—Hyoscyamine—pancreatitis	0.000342	0.00509	CcSEcCtD
Naltrexone—Fatigue—Hyoscyamine—pancreatitis	0.000332	0.00494	CcSEcCtD
Naltrexone—Pain—Hyoscyamine—pancreatitis	0.000329	0.0049	CcSEcCtD
Naltrexone—Constipation—Hyoscyamine—pancreatitis	0.000329	0.0049	CcSEcCtD
Naltrexone—Feeling abnormal—Hyoscyamine—pancreatitis	0.000317	0.00472	CcSEcCtD
Naltrexone—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.000315	0.00468	CcSEcCtD
Naltrexone—Urticaria—Hyoscyamine—pancreatitis	0.000306	0.00455	CcSEcCtD
Naltrexone—Body temperature increased—Hyoscyamine—pancreatitis	0.000304	0.00453	CcSEcCtD
Naltrexone—Abdominal pain—Hyoscyamine—pancreatitis	0.000304	0.00453	CcSEcCtD
Naltrexone—Hypersensitivity—Hyoscyamine—pancreatitis	0.000283	0.00422	CcSEcCtD
Naltrexone—Asthenia—Hyoscyamine—pancreatitis	0.000276	0.00411	CcSEcCtD
Naltrexone—Pruritus—Hyoscyamine—pancreatitis	0.000272	0.00405	CcSEcCtD
Naltrexone—Diarrhoea—Hyoscyamine—pancreatitis	0.000263	0.00392	CcSEcCtD
Naltrexone—Dizziness—Hyoscyamine—pancreatitis	0.000254	0.00379	CcSEcCtD
Naltrexone—Vomiting—Hyoscyamine—pancreatitis	0.000245	0.00364	CcSEcCtD
Naltrexone—Rash—Hyoscyamine—pancreatitis	0.000243	0.00361	CcSEcCtD
Naltrexone—Dermatitis—Hyoscyamine—pancreatitis	0.000242	0.00361	CcSEcCtD
Naltrexone—Headache—Hyoscyamine—pancreatitis	0.000241	0.00359	CcSEcCtD
Naltrexone—Nausea—Hyoscyamine—pancreatitis	0.000229	0.0034	CcSEcCtD
Naltrexone—Naloxone—ALB—pancreatitis	0.000196	0.111	CrCbGaD
Naltrexone—OPRD1—Signaling by GPCR—PPP3CA—pancreatitis	3.9e-05	0.00123	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—CXCL8—pancreatitis	3.89e-05	0.00123	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—pancreatitis	3.88e-05	0.00122	CbGpPWpGaD
Naltrexone—UGT1A1—NRF2 pathway—TGFB1—pancreatitis	3.87e-05	0.00122	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—BDKRB2—pancreatitis	3.87e-05	0.00122	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PNLIP—pancreatitis	3.86e-05	0.00122	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CCL5—pancreatitis	3.86e-05	0.00122	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CCKAR—pancreatitis	3.86e-05	0.00122	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—SCT—pancreatitis	3.83e-05	0.00121	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CASR—pancreatitis	3.83e-05	0.00121	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CNR1—pancreatitis	3.8e-05	0.0012	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CX3CL1—pancreatitis	3.75e-05	0.00118	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL1B—pancreatitis	3.74e-05	0.00118	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—SST—pancreatitis	3.74e-05	0.00118	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—CASP3—pancreatitis	3.73e-05	0.00118	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	3.72e-05	0.00118	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—GCG—pancreatitis	3.67e-05	0.00116	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCK—pancreatitis	3.65e-05	0.00115	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—MTNR1B—pancreatitis	3.65e-05	0.00115	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—SST—pancreatitis	3.61e-05	0.00114	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—CCL2—pancreatitis	3.59e-05	0.00113	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—PTHLH—pancreatitis	3.58e-05	0.00113	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—SMO—pancreatitis	3.58e-05	0.00113	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—XDH—pancreatitis	3.58e-05	0.00113	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CNR2—pancreatitis	3.56e-05	0.00112	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—TACR1—pancreatitis	3.56e-05	0.00112	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—KNG1—pancreatitis	3.52e-05	0.00111	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—BDKRB2—pancreatitis	3.51e-05	0.00111	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCKAR—pancreatitis	3.5e-05	0.00111	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	3.49e-05	0.0011	CbGpPWpGaD
Naltrexone—OPRM1—G alpha (i) signalling events—CXCL8—pancreatitis	3.47e-05	0.0011	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PPY—pancreatitis	3.46e-05	0.00109	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CNR1—pancreatitis	3.45e-05	0.00109	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—PPP3CA—pancreatitis	3.42e-05	0.00108	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—HTR2A—pancreatitis	3.4e-05	0.00107	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—BDKRB2—pancreatitis	3.39e-05	0.00107	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ADH1B—pancreatitis	3.34e-05	0.00105	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—PTHLH—pancreatitis	3.33e-05	0.00105	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—GCG—pancreatitis	3.33e-05	0.00105	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CNR1—pancreatitis	3.33e-05	0.00105	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—SST—pancreatitis	3.28e-05	0.00103	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	3.27e-05	0.00103	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PNLIP—pancreatitis	3.26e-05	0.00103	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—GCG—pancreatitis	3.21e-05	0.00101	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—KNG1—pancreatitis	3.2e-05	0.00101	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CCL2—pancreatitis	3.15e-05	0.000992	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—KNG1—pancreatitis	3.09e-05	0.000974	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—BDKRB2—pancreatitis	3.08e-05	0.000972	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SCT—pancreatitis	3.05e-05	0.000963	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—FGG—pancreatitis	3.05e-05	0.000963	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CASR—pancreatitis	3.05e-05	0.000963	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—SST—pancreatitis	3.05e-05	0.000962	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—TRPV1—pancreatitis	3.04e-05	0.000959	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—SMO—pancreatitis	3.03e-05	0.000955	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PTHLH—pancreatitis	3.03e-05	0.000955	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CNR1—pancreatitis	3.02e-05	0.000954	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CX3CL1—pancreatitis	2.99e-05	0.000944	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CCL5—pancreatitis	2.94e-05	0.000928	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PPY—pancreatitis	2.93e-05	0.000924	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—GCG—pancreatitis	2.92e-05	0.000921	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MTNR1B—pancreatitis	2.91e-05	0.000919	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCK—pancreatitis	2.91e-05	0.000919	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—TGFB1—pancreatitis	2.9e-05	0.000916	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PPP3CA—pancreatitis	2.89e-05	0.000911	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—BDKRB2—pancreatitis	2.87e-05	0.000904	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CNR2—pancreatitis	2.84e-05	0.000895	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—A2M—pancreatitis	2.84e-05	0.000895	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TACR1—pancreatitis	2.84e-05	0.000895	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—CXCL8—pancreatitis	2.84e-05	0.000895	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CNR1—pancreatitis	2.81e-05	0.000888	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—KNG1—pancreatitis	2.8e-05	0.000884	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCKAR—pancreatitis	2.79e-05	0.000881	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—SST—pancreatitis	2.77e-05	0.000873	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	2.76e-05	0.000871	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—GCG—pancreatitis	2.72e-05	0.000857	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—TNF—pancreatitis	2.71e-05	0.000855	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SCT—pancreatitis	2.68e-05	0.000844	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CASR—pancreatitis	2.68e-05	0.000844	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—FGG—pancreatitis	2.68e-05	0.000844	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CCL5—pancreatitis	2.67e-05	0.000843	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PLA2G1B—pancreatitis	2.66e-05	0.00084	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CCL2—pancreatitis	2.66e-05	0.000839	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CX3CL1—pancreatitis	2.62e-05	0.000828	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—KNG1—pancreatitis	2.61e-05	0.000823	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—BDKRB2—pancreatitis	2.6e-05	0.000821	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—FGA—pancreatitis	2.6e-05	0.000819	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR2A—pancreatitis	2.59e-05	0.000818	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CCL5—pancreatitis	2.58e-05	0.000814	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—A2M—pancreatitis	2.57e-05	0.000811	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CNR1—pancreatitis	2.55e-05	0.000806	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCK—pancreatitis	2.55e-05	0.000806	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MTNR1B—pancreatitis	2.55e-05	0.000806	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CTRB2—pancreatitis	2.55e-05	0.000804	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CNR2—pancreatitis	2.49e-05	0.000785	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—A2M—pancreatitis	2.49e-05	0.000785	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TACR1—pancreatitis	2.49e-05	0.000785	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CXCL8—pancreatitis	2.49e-05	0.000785	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—GCG—pancreatitis	2.47e-05	0.000779	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCKAR—pancreatitis	2.45e-05	0.000772	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PTHLH—pancreatitis	2.41e-05	0.000761	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SMO—pancreatitis	2.41e-05	0.000761	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—KNG1—pancreatitis	2.37e-05	0.000747	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—FGB—pancreatitis	2.36e-05	0.000745	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR2A—pancreatitis	2.36e-05	0.000743	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ALDH2—pancreatitis	2.35e-05	0.000742	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CCL5—pancreatitis	2.34e-05	0.000739	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PPP3CA—pancreatitis	2.3e-05	0.000726	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—FGA—pancreatitis	2.28e-05	0.000718	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR2A—pancreatitis	2.27e-05	0.000718	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—FGG—pancreatitis	2.26e-05	0.000714	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SCT—pancreatitis	2.26e-05	0.000714	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CASR—pancreatitis	2.26e-05	0.000714	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CX3CL1—pancreatitis	2.22e-05	0.0007	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—FDX1—pancreatitis	2.21e-05	0.000697	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SST—pancreatitis	2.21e-05	0.000696	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—DUSP6—pancreatitis	2.19e-05	0.00069	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CCL5—pancreatitis	2.18e-05	0.000688	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCK—pancreatitis	2.16e-05	0.000681	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MTNR1B—pancreatitis	2.16e-05	0.000681	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PTHLH—pancreatitis	2.12e-05	0.000668	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SMO—pancreatitis	2.12e-05	0.000668	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CNR2—pancreatitis	2.1e-05	0.000664	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—A2M—pancreatitis	2.1e-05	0.000664	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TACR1—pancreatitis	2.1e-05	0.000664	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CXCL8—pancreatitis	2.1e-05	0.000663	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—BDKRB2—pancreatitis	2.07e-05	0.000655	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—FGB—pancreatitis	2.07e-05	0.000653	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCKAR—pancreatitis	2.07e-05	0.000653	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR2A—pancreatitis	2.07e-05	0.000652	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—pancreatitis	2.06e-05	0.000649	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ADH4—pancreatitis	2.05e-05	0.000648	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CNR1—pancreatitis	2.04e-05	0.000643	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PPP3CA—pancreatitis	2.02e-05	0.000637	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatitis	1.98e-05	0.000625	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCL5—pancreatitis	1.98e-05	0.000625	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—GCG—pancreatitis	1.97e-05	0.000621	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SST—pancreatitis	1.93e-05	0.000611	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PRSS1—pancreatitis	1.93e-05	0.000609	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—FGA—pancreatitis	1.92e-05	0.000607	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR2A—pancreatitis	1.92e-05	0.000607	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DUSP6—pancreatitis	1.92e-05	0.000605	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—KNG1—pancreatitis	1.89e-05	0.000596	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CCL2—pancreatitis	1.84e-05	0.000581	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	1.84e-05	0.00058	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PNLIP—pancreatitis	1.83e-05	0.000578	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PRSS3—pancreatitis	1.83e-05	0.000578	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—BDKRB2—pancreatitis	1.82e-05	0.000574	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PTHLH—pancreatitis	1.79e-05	0.000564	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SMO—pancreatitis	1.79e-05	0.000564	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CNR1—pancreatitis	1.79e-05	0.000563	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GCG—pancreatitis	1.78e-05	0.000562	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—FGB—pancreatitis	1.75e-05	0.000552	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR2A—pancreatitis	1.75e-05	0.000551	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PDGFA—pancreatitis	1.74e-05	0.000548	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GCG—pancreatitis	1.72e-05	0.000544	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PPP3CA—pancreatitis	1.71e-05	0.000538	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—KNG1—pancreatitis	1.66e-05	0.000522	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—XDH—pancreatitis	1.64e-05	0.000518	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SST—pancreatitis	1.64e-05	0.000516	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DUSP6—pancreatitis	1.62e-05	0.000511	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CCL2—pancreatitis	1.61e-05	0.000509	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CXCL8—pancreatitis	1.6e-05	0.000506	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCL5—pancreatitis	1.58e-05	0.000498	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—LPL—pancreatitis	1.54e-05	0.000487	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—BDKRB2—pancreatitis	1.54e-05	0.000485	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ADH1B—pancreatitis	1.53e-05	0.000483	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PDGFA—pancreatitis	1.52e-05	0.00048	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CNR1—pancreatitis	1.51e-05	0.000476	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SPP1—pancreatitis	1.46e-05	0.000461	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GCG—pancreatitis	1.46e-05	0.00046	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CXCL8—pancreatitis	1.46e-05	0.000459	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	1.43e-05	0.000452	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CXCL8—pancreatitis	1.41e-05	0.000443	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—KNG1—pancreatitis	1.4e-05	0.000441	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—LPL—pancreatitis	1.4e-05	0.000441	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR2A—pancreatitis	1.39e-05	0.000439	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCL5—pancreatitis	1.38e-05	0.000437	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCL2—pancreatitis	1.36e-05	0.00043	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—LPL—pancreatitis	1.35e-05	0.000427	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	1.34e-05	0.000422	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	1.33e-05	0.000419	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—LEP—pancreatitis	1.29e-05	0.000408	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PDGFA—pancreatitis	1.29e-05	0.000406	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SPP1—pancreatitis	1.28e-05	0.000404	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CXCL8—pancreatitis	1.28e-05	0.000403	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PLA2G1B—pancreatitis	1.22e-05	0.000385	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR2A—pancreatitis	1.22e-05	0.000385	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CXCL8—pancreatitis	1.19e-05	0.000375	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—A2M—pancreatitis	1.18e-05	0.000372	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCL5—pancreatitis	1.17e-05	0.000369	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—NRAS—pancreatitis	1.17e-05	0.000368	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—LPL—pancreatitis	1.14e-05	0.000361	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—LEP—pancreatitis	1.13e-05	0.000358	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—INS—pancreatitis	1.11e-05	0.000349	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCL2—pancreatitis	1.09e-05	0.000343	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SPP1—pancreatitis	1.08e-05	0.000342	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALDH2—pancreatitis	1.08e-05	0.00034	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CXCL8—pancreatitis	1.08e-05	0.00034	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR2A—pancreatitis	1.03e-05	0.000325	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—NRAS—pancreatitis	1.02e-05	0.000323	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PPARG—pancreatitis	1.02e-05	0.000322	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—KRAS—pancreatitis	1e-05	0.000317	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—INS—pancreatitis	1e-05	0.000316	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—INS—pancreatitis	9.69e-06	0.000306	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—LEP—pancreatitis	9.59e-06	0.000303	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCL2—pancreatitis	9.53e-06	0.000301	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MDM2—pancreatitis	9.19e-06	0.00029	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ALB—pancreatitis	9.18e-06	0.00029	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	8.99e-06	0.000284	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—KRAS—pancreatitis	8.81e-06	0.000278	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—NRAS—pancreatitis	8.65e-06	0.000273	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CXCL8—pancreatitis	8.6e-06	0.000271	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HRAS—pancreatitis	8.54e-06	0.00027	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CASP3—pancreatitis	8.23e-06	0.00026	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—INS—pancreatitis	8.19e-06	0.000258	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GCG—pancreatitis	8.18e-06	0.000258	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL6—pancreatitis	8.17e-06	0.000258	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MDM2—pancreatitis	8.06e-06	0.000254	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCL2—pancreatitis	8.06e-06	0.000254	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PTGS2—pancreatitis	8.03e-06	0.000254	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCL8—pancreatitis	7.54e-06	0.000238	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HRAS—pancreatitis	7.49e-06	0.000236	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—KRAS—pancreatitis	7.45e-06	0.000235	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CASP3—pancreatitis	7.21e-06	0.000228	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL6—pancreatitis	7.17e-06	0.000226	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NRAS—pancreatitis	6.9e-06	0.000218	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MDM2—pancreatitis	6.81e-06	0.000215	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—LPL—pancreatitis	6.42e-06	0.000202	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TGFB1—pancreatitis	6.41e-06	0.000202	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCL8—pancreatitis	6.37e-06	0.000201	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HRAS—pancreatitis	6.33e-06	0.0002	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CASP3—pancreatitis	6.1e-06	0.000192	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL6—pancreatitis	6.06e-06	0.000191	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NRAS—pancreatitis	6.05e-06	0.000191	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—KRAS—pancreatitis	5.94e-06	0.000187	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TGFB1—pancreatitis	5.62e-06	0.000177	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—KRAS—pancreatitis	5.2e-06	0.000164	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NRAS—pancreatitis	5.11e-06	0.000161	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HRAS—pancreatitis	5.05e-06	0.000159	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL6—pancreatitis	4.83e-06	0.000152	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TGFB1—pancreatitis	4.75e-06	0.00015	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PPARG—pancreatitis	4.68e-06	0.000148	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—INS—pancreatitis	4.59e-06	0.000145	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HRAS—pancreatitis	4.42e-06	0.00014	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—KRAS—pancreatitis	4.4e-06	0.000139	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL6—pancreatitis	4.23e-06	0.000134	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALB—pancreatitis	4.21e-06	0.000133	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HRAS—pancreatitis	3.74e-06	0.000118	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PTGS2—pancreatitis	3.69e-06	0.000116	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL6—pancreatitis	3.58e-06	0.000113	CbGpPWpGaD
